Format

Send to

Choose Destination
PLoS Negl Trop Dis. 2015 May 7;9(5):e0003655. doi: 10.1371/journal.pntd.0003655. eCollection 2015 May.

A critical assessment of vector control for dengue prevention.

Author information

1
Department of Biological Sciences and Eck Institute for Global Health, University of Notre Dame, Notre Dame, Indiana, United States of America.
2
Department of Entomology, North Carolina State University, Raleigh, North Carolina, United States of America.
3
Department of Biological Sciences and Eck Institute for Global Health, University of Notre Dame, Notre Dame, Indiana, United States of America; Fogarty International Center, National Institutes of Health, Bethesda, Maryland, United States of America.
4
Fogarty International Center, National Institutes of Health, Bethesda, Maryland, United States of America; Department of Epidemiology and Biostatistics, Indiana University School of Public Health, Bloomington, Indiana, United States of America.
5
Department of Entomology and Nematology, University of California, Davis, Davis, California, United States of America; United States Naval Medical Research Unit, No. 6, Iquitos, Peru.
6
College of Public Health, Medical and Veterinary Sciences, James Cook University, Cairns, Australia.
7
Emerging Infectious Diseases Program, Duke-NUS Graduate Medical School, Singapore, Singapore; Partnership for Dengue Control, Fondation Mérieux, Lyon, France.
8
Partnership for Dengue Control, Fondation Mérieux, Lyon, France.
9
Fogarty International Center, National Institutes of Health, Bethesda, Maryland, United States of America; Department of Entomology and Nematology, University of California, Davis, Davis, California, United States of America; Partnership for Dengue Control, Fondation Mérieux, Lyon, France.

Abstract

Recently, the Vaccines to Vaccinate (v2V) initiative was reconfigured into the Partnership for Dengue Control (PDC), a multi-sponsored and independent initiative. This redirection is consistent with the growing consensus among the dengue-prevention community that no single intervention will be sufficient to control dengue disease. The PDC's expectation is that when an effective dengue virus (DENV) vaccine is commercially available, the public health community will continue to rely on vector control because the two strategies complement and enhance one another. Although the concept of integrated intervention for dengue prevention is gaining increasingly broader acceptance, to date, no consensus has been reached regarding the details of how and what combination of approaches can be most effectively implemented to manage disease. To fill that gap, the PDC proposed a three step process: (1) a critical assessment of current vector control tools and those under development, (2) outlining a research agenda for determining, in a definitive way, what existing tools work best, and (3) determining how to combine the best vector control options, which have systematically been defined in this process, with DENV vaccines. To address the first step, the PDC convened a meeting of international experts during November 2013 in Washington, DC, to critically assess existing vector control interventions and tools under development. This report summarizes those deliberations.

PMID:
25951103
PMCID:
PMC4423954
DOI:
10.1371/journal.pntd.0003655
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Public Library of Science Icon for PubMed Central
Loading ...
Support Center